Dr. Madhavi Katikaneni, MD

Dr. Katikaneni practices at Peekskill Cortlandt Dialysis Center in Ossining, New York.

Dr. Katikaneni's NPI, 1073845020, was assigned on February 2, 2010. Dr. Katikaneni graduated from Osmania Medical College NTR UHS in 2001. Dr. Katikaneni holds New York license 270344.

Dr. Katikaneni's primary practice is Peekskill Cortlandt Dialysis Center, at 47 Hudson St, Ossining, NY 10562 in Westchester County. The practice phone is (914) 788-9326.

Dr. Katikaneni's primary practice is Peekskill Cortlandt Dialysis Center in Ossining, New York. Dr. Katikaneni is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is The Westchester Medical Practice. Dmand AI also links Dr. Katikaneni to 2 more hospitals, 2 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katikaneni practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Katikaneni's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Katikaneni is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Katikaneni's licenses on file in 2 states: New York and Texas.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Katikaneni treats.

CMS data shows 1,481 Medicare services from Dr. Katikaneni across 16 procedure codes in 2024, for 392 Medicare patients. Medicare paid $174,920 for them.

CMS counts 392 Medicare patients who saw Dr. Katikaneni in 2024. The largest group is 75 to 84, with 140 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 3.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katikaneni's median patient age at 71, with 41% women.

In 2024, Dr. Katikaneni wrote 945 Medicare Part D claims for 143 patients. 73% of them were for generic drugs. CMS names the drug for 789 of them, across 27 drugs with 11 or more claims each, at $211,261 in total drug cost. In 2023, CMS named 759 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Katikaneni for performance year 2024, reported through an alternative payment model (APM). Dr. Katikaneni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Katikaneni as offering telehealth.

Dmand AI links 5 papers to Dr. Katikaneni in 2020. 2020 was the busiest year, with 2. The most frequent topics are Kidney Failure, Chronic and Renal Dialysis. Dr. Katikaneni's most frequent co-authors are Lin N. Lwin, MD, Hugo J. Villanueva, MD and Jacob S. Stevens, MD.

CMS Open Payments shows 151 general payments to Dr. Katikaneni from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $426.

Dr. Katikaneni graduated from Osmania Medical College NTR UHS in 2001.

Dr. Katikaneni is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and MVP Health Care. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.